Sotera Health Company

NasdaqGS:SHC Stock Report

Market Cap: US$3.2b

Sotera Health Future Growth

Future criteria checks 4/6

Sotera Health is forecast to grow earnings and revenue by 49.9% and 5.6% per annum respectively. EPS is expected to grow by 49.1% per annum. Return on equity is forecast to be 45.1% in 3 years.

Key information

49.9%

Earnings growth rate

49.14%

EPS growth rate

Life Sciences earnings growth14.7%
Revenue growth rate5.6%
Future return on equity45.06%
Analyst coverage

Good

Last updated25 Jul 2025

Recent future growth updates

Recent updates

These 4 Measures Indicate That Sotera Health (NASDAQ:SHC) Is Using Debt Extensively

Jul 17
These 4 Measures Indicate That Sotera Health (NASDAQ:SHC) Is Using Debt Extensively

Is There An Opportunity With Sotera Health Company's (NASDAQ:SHC) 48% Undervaluation?

Jun 12
Is There An Opportunity With Sotera Health Company's (NASDAQ:SHC) 48% Undervaluation?

Sotera Health Company's (NASDAQ:SHC) 28% Price Boost Is Out Of Tune With Revenues

May 13
Sotera Health Company's (NASDAQ:SHC) 28% Price Boost Is Out Of Tune With Revenues

What Does Sotera Health Company's (NASDAQ:SHC) Share Price Indicate?

Apr 24
What Does Sotera Health Company's (NASDAQ:SHC) Share Price Indicate?

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Mar 31
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

There May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing Earnings

Mar 07
There May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing Earnings

Some Confidence Is Lacking In Sotera Health Company's (NASDAQ:SHC) P/S

Feb 26
Some Confidence Is Lacking In Sotera Health Company's (NASDAQ:SHC) P/S

Why Sotera Health Company (NASDAQ:SHC) Could Be Worth Watching

Jan 06
Why Sotera Health Company (NASDAQ:SHC) Could Be Worth Watching

Here's Why Sotera Health (NASDAQ:SHC) Has A Meaningful Debt Burden

Dec 05
Here's Why Sotera Health (NASDAQ:SHC) Has A Meaningful Debt Burden
author-image

Sterigenics' Expansion And Smart Pricing Poised For Sustained Revenue And Margin Growth

Sotera Health's strategic pricing and capacity expansion reflect confidence in maintaining or growing future revenue and net margins, despite economic pressures.

Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable

Sep 02
Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable

Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Jun 25
Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

May 30
Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Earnings and Revenue Growth Forecasts

NasdaqGS:SHC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,2861763452724
12/31/20261,2091592882996
12/31/20251,142992012306
3/31/20251,10725106270N/A
12/31/20241,1004445224N/A
9/30/20241,12071104282N/A
6/30/20241,0984032226N/A
3/31/20241,07755-377-172N/A
12/31/20231,04951-363-148N/A
9/30/2023991-306-381-159N/A
6/30/2023976-268-342-133N/A
3/31/2023988-26170262N/A
12/31/20221,004-23496278N/A
9/30/202299312190242N/A
6/30/2022971123127256N/A
3/31/2022956135159275N/A
12/31/2021931115179282N/A
9/30/202190736156237N/A
6/30/20218819127202N/A
3/31/2021842-26110171N/A
12/31/2020818-3967121N/A
9/30/2020795-2355109N/A
6/30/2020790-2868124N/A
3/31/2020772-2958116N/A
12/31/2019778-2192149N/A
12/31/2018746-6N/A120N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SHC's forecast earnings growth (49.9% per year) is above the savings rate (2.9%).

Earnings vs Market: SHC's earnings (49.9% per year) are forecast to grow faster than the US market (14.7% per year).

High Growth Earnings: SHC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SHC's revenue (5.6% per year) is forecast to grow slower than the US market (9.2% per year).

High Growth Revenue: SHC's revenue (5.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SHC's Return on Equity is forecast to be very high in 3 years time (45.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/03 01:40
End of Day Share Price 2025/08/01 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sotera Health Company is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PolarkBaird
Luke SergottBarclays
Patrick DonnellyCitigroup Inc